The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Time to quality of life (QoL) improvement or deterioration in patients (pts) with primary advanced or recurrent endometrial cancer (pA/R EC) treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial.
 
Florian Heitz
Honoraria - Amedes; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Novocure; PharmaMar; Roche; Tesaro/GSK; Zai Lab
(OPTIONAL) Uncompensated Relationships - New Oncology/Siemens
 
Lyndsay Willmott
Consulting or Advisory Role - AstraZeneca; ImmunoGen/AbbVie; Seagen/Pfizer
Speakers' Bureau - AstraZeneca; Eisai; ImmunoGen/AbbVie; MSD; Seagen/Pfizer
 
Hanne From Mathiesen
No Relationships to Disclose
 
Lucy Gilbert
Honoraria - GlaxoSmithKline; Merck; Repare Therapeutics
Consulting or Advisory Role - Corcept Therapeutics; Eisai; GlaxoSmithKline; Immunogen; Kora Healthcare; Merck
Research Funding - Alkermes (Inst); Ascendis Pharma (Inst); AstraZeneca (Inst); Corcept Therapeutics (Inst); Esperas Pharma (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Immunogen (Inst); IMV (Inst); K-Group Beta (Inst); Karyopharm Therapeutics (Inst); Merck Sharp & Dohme (Inst); Mersana (Inst); Novocure (Inst); OncoQuest (Inst); Repare Therapeutics (Inst); Roche (Inst); Seagen (Inst); Shattuck Labs (Inst); Sutro BioPharma Inc (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Corcept Therapeutics; Eisai; EndomEra; GlaxoSmithKline; GOG Foundation; Merck; Zentalis
 
Alberto Mendivil
No Relationships to Disclose
 
Laura Zavallone
No Relationships to Disclose
 
Ashley Stuckey
No Relationships to Disclose
 
Zoltán Novák
Honoraria - AstraZeneca; Richter Gedeon; Sofmedica
Speakers' Bureau - MSD Oncology; Richter Gedeon
Travel, Accommodations, Expenses - GlaxoSmithKline
 
John Diaz
No Relationships to Disclose
 
Annemarie Thijs
No Relationships to Disclose
 
Michael Teneriello
No Relationships to Disclose
 
Mitchell Edelson
Employment - Pfizer (I)
Travel, Accommodations, Expenses - Intuitive Surgical
 
Robert Holloway
Consulting or Advisory Role - Genelux; GlaxoSmithKline
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; Merck; Natera
(OPTIONAL) Uncompensated Relationships - Genelux
 
Amy Armstrong
No Relationships to Disclose
 
Barbara Buttin
No Relationships to Disclose
 
Matthew Powell
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline/Tesaro; GOG partners; Immunogen; Merck; Seagen; Tesaro
Research Funding - GlaxoSmithKline/Tesaro (Inst)
 
Bernd Westermayer
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Qin Shen
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Mansoor Mirza
Leadership - Karyopharm Therapeutics; Sera Prognostics
Stock and Other Ownership Interests - Karyopharm Therapeutics; Sera Prognostics
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Takeda; Zai Lab
Consulting or Advisory Role - Abbvie; Allarity Therapeutics; AstraZeneca; BIOCAD; BioNTech; Daiichi Sankyo; Eisai; Genmab; GlaxoSmithKline; ImmunoGen/AbbVie; Incyte; Karyopharm Therapeutics; MSD; Regeneron; Zai Lab
Speakers' Bureau - AstraZeneca; Eisai; GlaxoSmithKline; Takeda; Zai Lab
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline
 
Kari Ring
No Relationships to Disclose